RecruitingPhase 1NCT06218914
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Sponsor: AstraZeneca
Dallas, TX · Galveston, TX · Houston, TX · +15 more sites
1 recruiting colorectal cancer studies with a site in Galveston, TX.
Sponsor: AstraZeneca
Dallas, TX · Galveston, TX · Houston, TX · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.